Updated Guidance for Medicare Advantage Organizations on Compliance Strategies
The Office of Inspector General (OIG) has issued revised guidance for Medicare Advantage Organizations (MAOs), focusing on compliance with Medicare Advantage (MA) regulations. This guidance provides valuable insights into the OIG's current enforcement priorities, derived from various audits and evaluations. While not obligatory, it offers a framework for MAOs to assess and enhance their compliance programs effectively.
The guidance indicates intensified scrutiny by the OIG, the Department of Justice (DOJ), and the Centers for Medicare and Medicaid Services (CMS) on critical areas such as risk adjustment and third-party oversight. To ensure regulatory compliance, MAOs should perform comprehensive reviews in line with CMS standards, particularly regarding access to care and provider network management. Timely updates to provider directories and adherence to network adequacy standards are essential to mitigate legal and compliance risks.
MAOs must ensure that enrollees receive medically necessary services, underscoring the need for formal utilization management committees. These committees should consider patient-specific circumstances and not rely solely on algorithms. The updated guidance also highlights the importance of oversight over delegated marketing and enrollment functions to prevent practices that could mislead beneficiaries.
The Anti-Kickback Statute and similar regulations require careful examination of financial relationships and marketing arrangements to avoid conflicts of interest. Compliance programs should monitor and manage these relationships to mitigate the risk of federal violations that might negatively affect enrollment decisions.
Risk adjustment data accuracy is another focal point, as inaccurate or unsupported submissions can lead to significant False Claims Act liabilities. Audits have uncovered issues such as the reporting of unsupported high-risk diagnoses, urging MAOs to ensure that all data submissions are thoroughly documented and validated.
The OIG's guidance underscores the importance of an overarching compliance program featuring board-level visibility and regular compliance reporting. MAOs are advised to address compliance risks proactively through strategic implementation of documented policies and rigorous oversight of all delegated functions. This proactive approach aligns with the industry's shift towards robust, proactive compliance frameworks.
For detailed guidance or professional advice related to Medicare Advantage compliance, industry stakeholders are encouraged to consult legal experts specializing in this area.